Unlock instant, AI-driven research and patent intelligence for your innovation.

Lung cancer organoid culture medium, culture reagent combination and culture method thereof

A culture method and organoid technology, which is applied in the field of lung cancer organoid culture medium and its culture reagent combination and culture, can solve the problems of long time required, slow construction process, high time cost of lung cancer organoids, etc., to achieve accelerated formation and growth, The effect of accelerating growth and shortening the enzymatic hydrolysis time

Active Publication Date: 2022-05-31
BEIJING DAXIANG BIOTECH CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, the amount of cells obtained is also very small. In order to harvest more cells and conduct downstream experiments, it takes longer, which makes the construction process of the entire organ slow, resulting in high time costs for lung cancer organoid research. In addition, more The most important thing is that after a period of time in vitro culture of organoids, EMT transition will occur, and the mesenchymal properties in vivo will be gradually lost, which will be quite different from the real tumor properties in vivo

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lung cancer organoid culture medium, culture reagent combination and culture method thereof
  • Lung cancer organoid culture medium, culture reagent combination and culture method thereof
  • Lung cancer organoid culture medium, culture reagent combination and culture method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

The second conditioned medium to the fourth conditioned medium was mixed as the first batch of conditioned medium; the fifth conditioned medium to

The eighth conditioned medium was mixed as the second batch of conditioned medium; the ninth conditioned medium to the twelfth conditioned medium were mixed.

The nutrient mix was used as the third batch of conditioned medium. And each batch of conditioned medium uses a 0.22 μm vacuum filter. cryopreservation

Parts minus 80 ℃.

S105, during use, will freeze the first batch of conditioned medium, the second batch of conditioned medium and the third batch of strips

The medium was thawed and mixed in an equal volume ratio as the target protein conditioned medium.

That is, adopt the purpose cell line of Wnt-3a, R-spondin1 and Noggin overexpressing cell line respectively to carry out respectively

Cultivate to obtain the respective corresponding Wnt-3a protein conditioned medium, R-spondin 1 protein conditioned medium and Noggin p...

Embodiment 2

Embodiment 3

[0147] Complete medium includes conditioned medium, basal medium, complex antibiotics and growth factors. Among them, conditional training

[0150]

[0152] The lung cancer organoid culture solution of this embodiment 3 is suitable for human lung cancer organoid culture solution.

[0159]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This application relates to the technical field of biological tissue engineering, and discloses a lung cancer organoid culture medium and its culture reagent combination and culture method. The lung cancer organoid culture medium includes complete medium and self-derived conditioned medium; complete medium includes conditioned culture Base, basal medium, compound antibiotics and growth factors; self-sourced conditioned medium is obtained by culturing fibroblasts extracted from lung cancer tissue using tumor-associated fibroblast medium. The synergy between the components of the culture medium accelerates the formation and growth of lung cancer organoid cells, increases the number of harvested cells and improves the culture speed; moreover, the organoids cultured in vitro are more bionic and can be applied to the personalized culture of lung cancer organoids , able to maintain the physical structure and pathological characteristics of each patient's primary tissue.

Description

Lung cancer organoid culture medium and its combination of culture reagents and culture method technical field The application relates to biological tissue engineering technical field, for example relates to a kind of lung cancer organoid culture fluid and culture test thereof. Agent combinations and culture methods. Background technique Lung cancer is one of the top ten malignant tumors in my country. At present, the etiology of lung cancer is not fully understood, and it is currently believed that the main It is the result of the combined effect of environmental factors and genetic factors. Lung cancer organoids are of great significance for research. Although there are currently Some studies on lung cancer organoid culture medium have reported, but the culture process is slow to grow, increasing the cost of time investment; Low. In the process of realizing the embodiment of the present application, it is found that there are at least the following problems in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/09C12N5/071
Inventor 肖荣荣刘建闯李珮文孙艳廷张晓会周宇
Owner BEIJING DAXIANG BIOTECH CO LTD